1,25-Dihyroxyvitamin D 3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5276-5282

  Kang, Seong Wook ^a,b   Kim, Sang Hyun ^a,c   Lee, Naeun ^a   Lee, Won Woo ^a,d   Hwang, Kyung A ^a,e   Shin, Min Sun ^a   Lee, Seung Hyun ^a,f   Kim, Wan Uk ^g   Kang, Insoo ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Chungnam National University   (South Korea)

^c Kangwon National University   (South Korea)

^d Seoul National University   (South Korea)

^e National Academy of Agricultural Science   (South Korea)

^f Konkuk University School of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; FOXP3 GENE; GENE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; INTRON; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; TARGET CELL; VITAMIN D RESPONSIVE ELEMENT;

ADULT; BASE SEQUENCE; BINDING SITES; CALCITRIOL; CONSERVED SEQUENCE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, CALCITRIOL; UP-REGULATION; VITAMIN D RESPONSE ELEMENT;

EID: 84862093116     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101211     Document Type: Article

References (46)

1. +regulatory T cells in the human immune system. Nat. Rev. Immunol. 10: 490-500.
2. + T cell lineage differentiation. Immunity 30: 646-655.
3. + regulatory T cells in autoimmune diseases. Nat. Clin. Pract. Rheumatol. 3: 619-626.
4. + regulatory T cells. Nat. Immunol. 4: 330-336.
5. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
6. + T regulatory cells. Nat. Immunol. 4: 337-342.
7. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21. (Pubitemid 32044513)
8. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73. (Pubitemid 32044521)
9. Pillai, V., S. B. Ortega, C. K. Wang, and N. J. Karandikar. 2007. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin. Immunol. 123: 18-29. (Pubitemid 46401504)
10. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
11. Wang, J., A. Ioan-Facsinay, E. I. van der Voort, T. W. Huizinga, and R. E. Toes. 2007. Transient expression of FOXP3 in human activated nonregulatory CD4+T cells. Eur. J. Immunol. 37: 129-138. (Pubitemid 46128793)
12. Kang, S. G., H. W. Lim, O. M. Andrisani, H. E. Broxmeyer, and C. H. Kim. 2007. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179: 3724-3733.
13. H17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
14. Schambach, F., M. Schupp, M. A. Lazar, and S. L. Reiner. 2007. Activation of retinoic acid receptor-α favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37: 2396-2399. (Pubitemid 47423609)
15. Mora, J. R., M. Iwata, and U. H. von Andrian. 2008. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 8: 685-698.
16. Huisman, A. M., K. P. White, A. Algra, M. Harth, R. Vieth, J. W. Jacobs, J. W. Bijlsma, and D. A. Bell. 2001. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J. Rheumatol. 28: 2535-2539. (Pubitemid 33031987)
17. 3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin. Rheumatol. 14: 397-400.
18. Kerr, G. S., I. Sabahi, J. S. Richards, L. Caplan, G. W. Cannon, A. Reimold, G. M. Thiele, D. Johnson, and T. R. Mikuls. 2011. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J. Rheumatol. 38: 53-59.
19. Haque, U. J., and S. J. Bartlett. 2010. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin. Exp. Rheumatol. 28: 745-747.
20. Arnson, Y., H. Amital, and Y. Shoenfeld. 2007. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann. Rheum. Dis. 66: 1137-1142. (Pubitemid 47309727)
21. Daniel, C., N. A. Sartory, N. Zahn, H. H. Radeke, and J. M. Stein. 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324: 23-33. (Pubitemid 350294165)
22. 3. Blood 106: 3490-3497.
23. + cells in the draining lymph nodes. J. Immunol. 179: 6273-6283.
24. Correale, J., M. C. Ysrraelit, and M. I. Gaitán. 2009. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132: 1146-1160.
25. 3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183: 5458-5467.
26. Carlberg, C., and S. Seuter. 2007. The vitamin D receptor. Dermatol. Clin. 25: 515-523, viii (viii.). (Pubitemid 47446078)
27. Tone, Y., K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9: 194-202.
28. Mantel, P. Y., N. Ouaked, B. Rückert, C. Karagiannidis, R. Welz, K. Blaser, and C. B. Schmidt-Weber. 2006. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176: 3593-3602. (Pubitemid 43364007)
29. 3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res. 35: 2734-2747.
30. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15: 5789-5799.
31. Cippitelli, M., and A. Santoni. 1998. Vitamin D3: a transcriptional modulator of the interferon-γ gene. Eur. J. Immunol. 28: 3017-3030. (Pubitemid 28470247)
32. Baban, B., P. R. Chandler, M. D. Sharma, J. Pihkala, P. A. Koni, D. H. Munn, and A. L. Mellor. 2009. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J. Immunol. 183: 2475-2483.
33. Chung, D. J., M. Rossi, E. Romano, J. Ghith, J. Yuan, D. H. Munn, and J. W. Young. 2009. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 114: 555-563.
34. Khoo, A. L., I. Joosten, M. Michels, R. Woestenenk, F. Preijers, X. H. He, M. G. Netea, A. J. van der Ven, and H. J. Koenen. 2011. 1,25- Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells. Immunology 134: 459-468.
35. Mayne, C. G., J. A. Spanier, L. M. Relland, C. B. Williams, and C. E. Hayes. 2011. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur. J. Immunol. 41: 822-832.
36. 3. J. Nutr. Sci. Vitaminol. (Tokyo) 36: 21-31.
37. 3attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12: 143-148.
38. 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87: 1103-1107.
39. 3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 177: 6030-6037.
40. Mathieu, C., C. Gysemans, A. Giulietti, and R. Bouillon. 2005. Vitamin D and diabetes. Diabetologia 48: 1247-1257. (Pubitemid 41186086)
41. hiT-regulatory cells. Blood 108: 253-261.
42. highregulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123: 79-89.
43. Huan, J., N. Culbertson, L. Spencer, R. Bartholomew, G. G. Burrows, Y. K. Chou, D. Bourdette, S. F. Ziegler, H. Offner, and A. A. Vandenbark. 2005. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81: 45-52. (Pubitemid 41139109)
44. +regulatory T cells in patients with systemic lupus erythematosus. Adv. Exp. Med. Biol. 601: 113-119.
45. high T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 153: 182-187.
46. high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178: 2579-2588.